Silo Pharma, Inc. (SILO)

Last Closing Price: 1.55 (2024-02-20)

Company Description

Silo Pharma. Inc. is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer's, and other rare neurological disorders. Silo Pharma. Inc. is based in ENGLEWOOD CLIFFS, NJ.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.07M
Net Income (Most Recent Fiscal Year) $-3.91M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 62.06
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.64
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -5885.37%
Net Margin (Trailing 12 Months) -5886.76%
Return on Equity (Trailing 12 Months) -47.69%
Return on Assets (Trailing 12 Months) -40.50%
Current Ratio (Most Recent Fiscal Quarter) 13.14
Quick Ratio (Most Recent Fiscal Quarter) 13.14
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $3.29
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 2.89M
Free Float 2.73M
Market Capitalization $4.47M
Average Volume (Last 20 Days) 0.12M
Beta (Past 60 Months) -0.05
Percentage Held By Insiders (Latest Annual Proxy Report) 5.56%
Percentage Held By Institutions (Latest 13F Reports) 3.22%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%